No Data
No Data
Ocuphire Pharma(OCUP.US) Officer Buys US$6,177.5 in Common Stock
$Ocuphire Pharma(OCUP.US)$ Officer Jayagopal Ashwath purchased 3,500 shares of common stock on May 22, 2024 at an average price of $1.765 for a total value of $6,177.5.Source: Announcement What is sta
Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed higher by 0.2% on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested i
Ocuphire Pharma(OCUP.US) Officer Buys US$8,772.5 in Common Stock
$Ocuphire Pharma(OCUP.US)$ Officer Magrath George purchased 5,000 shares of common stock on May 17, 2024 at an average price of $1.7545 for a total value of $8,772.5.Source: Announcement What is state
Ocuphire Pharma Is Maintained at Buy by Canaccord Genuity
Ocuphire Pharma Is Maintained at Buy by Canaccord Genuity
Canaccord Genuity Maintains Buy on Ocuphire Pharma, Lowers Price Target to $18
Canaccord Genuity analyst John Newman maintains Ocuphire Pharma with a Buy and lowers the price target from $22 to $18.
HC Wainwright & Co. : The Ocuphire Pharma (OCUP.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $20.00.
HC Wainwright & Co. : The Ocuphire Pharma (OCUP.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $20.00.